Introduction – Company Background

GuangXin Industrial Co., Ltd. is a specialized manufacturer dedicated to the development and production of high-quality insoles.

With a strong foundation in material science and footwear ergonomics, we serve as a trusted partner for global brands seeking reliable insole solutions that combine comfort, functionality, and design.

With years of experience in insole production and OEM/ODM services, GuangXin has successfully supported a wide range of clients across various industries—including sportswear, health & wellness, orthopedic care, and daily footwear.

From initial prototyping to mass production, we provide comprehensive support tailored to each client’s market and application needs.

At GuangXin, we are committed to quality, innovation, and sustainable development. Every insole we produce reflects our dedication to precision craftsmanship, forward-thinking design, and ESG-driven practices.

By integrating eco-friendly materials, clean production processes, and responsible sourcing, we help our partners meet both market demand and environmental goals.

Core Strengths in Insole Manufacturing

At GuangXin Industrial, our core strength lies in our deep expertise and versatility in insole and pillow manufacturing. We specialize in working with a wide range of materials, including PU (polyurethane), natural latex, and advanced graphene composites, to develop insoles and pillows that meet diverse performance, comfort, and health-support needs.

Whether it's cushioning, support, breathability, or antibacterial function, we tailor material selection to the exact requirements of each project-whether for foot wellness or ergonomic sleep products.

We provide end-to-end manufacturing capabilities under one roof—covering every stage from material sourcing and foaming, to precision molding, lamination, cutting, sewing, and strict quality control. This full-process control not only ensures product consistency and durability, but also allows for faster lead times and better customization flexibility.

With our flexible production capacity, we accommodate both small batch custom orders and high-volume mass production with equal efficiency. Whether you're a startup launching your first insole or pillow line, or a global brand scaling up to meet market demand, GuangXin is equipped to deliver reliable OEM/ODM solutions that grow with your business.

Customization & OEM/ODM Flexibility

GuangXin offers exceptional flexibility in customization and OEM/ODM services, empowering our partners to create insole products that truly align with their brand identity and target market. We develop insoles tailored to specific foot shapes, end-user needs, and regional market preferences, ensuring optimal fit and functionality.

Our team supports comprehensive branding solutions, including logo printing, custom packaging, and product integration support for marketing campaigns. Whether you're launching a new product line or upgrading an existing one, we help your vision come to life with attention to detail and consistent brand presentation.

With fast prototyping services and efficient lead times, GuangXin helps reduce your time-to-market and respond quickly to evolving trends or seasonal demands. From concept to final production, we offer agile support that keeps you ahead of the competition.

Quality Assurance & Certifications

Quality is at the heart of everything we do. GuangXin implements a rigorous quality control system at every stage of production—ensuring that each insole meets the highest standards of consistency, comfort, and durability.

We provide a variety of in-house and third-party testing options, including antibacterial performance, odor control, durability testing, and eco-safety verification, to meet the specific needs of our clients and markets.

Our products are fully compliant with international safety and environmental standards, such as REACH, RoHS, and other applicable export regulations. This ensures seamless entry into global markets while supporting your ESG and product safety commitments.

ESG-Oriented Sustainable Production

At GuangXin Industrial, we are committed to integrating ESG (Environmental, Social, and Governance) values into every step of our manufacturing process. We actively pursue eco-conscious practices by utilizing eco-friendly materials and adopting low-carbon production methods to reduce environmental impact.

To support circular economy goals, we offer recycled and upcycled material options, including innovative applications such as recycled glass and repurposed LCD panel glass. These materials are processed using advanced techniques to retain performance while reducing waste—contributing to a more sustainable supply chain.

We also work closely with our partners to support their ESG compliance and sustainability reporting needs, providing documentation, traceability, and material data upon request. Whether you're aiming to meet corporate sustainability targets or align with global green regulations, GuangXin is your trusted manufacturing ally in building a better, greener future.

Let’s Build Your Next Insole Success Together

Looking for a reliable insole manufacturing partner that understands customization, quality, and flexibility? GuangXin Industrial Co., Ltd. specializes in high-performance insole production, offering tailored solutions for brands across the globe. Whether you're launching a new insole collection or expanding your existing product line, we provide OEM/ODM services built around your unique design and performance goals.

From small-batch custom orders to full-scale mass production, our flexible insole manufacturing capabilities adapt to your business needs. With expertise in PU, latex, and graphene insole materials, we turn ideas into functional, comfortable, and market-ready insoles that deliver value.

Contact us today to discuss your next insole project. Let GuangXin help you create custom insoles that stand out, perform better, and reflect your brand’s commitment to comfort, quality, and sustainability.

🔗 Learn more or get in touch:
🌐 Website: https://www.deryou-tw.com/
📧 Email: shela.a9119@msa.hinet.net
📘 Facebook: facebook.com/deryou.tw
📷 Instagram: instagram.com/deryou.tw

Thailand ODM expert for comfort products

Are you looking for a trusted and experienced manufacturing partner that can bring your comfort-focused product ideas to life? GuangXin Industrial Co., Ltd. is your ideal OEM/ODM supplier, specializing in insole production, pillow manufacturing, and advanced graphene product design.

With decades of experience in insole OEM/ODM, we provide full-service manufacturing—from PU and latex to cutting-edge graphene-infused insoles—customized to meet your performance, support, and breathability requirements. Our production process is vertically integrated, covering everything from material sourcing and foaming to molding, cutting, and strict quality control.Graphene sheet OEM supplier Vietnam

Beyond insoles, GuangXin also offers pillow OEM/ODM services with a focus on ergonomic comfort and functional innovation. Whether you need memory foam, latex, or smart material integration for neck and sleep support, we deliver tailor-made solutions that reflect your brand’s values.

We are especially proud to lead the way in ESG-driven insole development. Through the use of recycled materials—such as repurposed LCD glass—and low-carbon production processes, we help our partners meet sustainability goals without compromising product quality. Our ESG insole solutions are designed not only for comfort but also for compliance with global environmental standards.Taiwan custom product OEM/ODM manufacturing factory

At GuangXin, we don’t just manufacture products—we create long-term value for your brand. Whether you're developing your first product line or scaling up globally, our flexible production capabilities and collaborative approach will help you go further, faster.Taiwan athletic insole OEM supplier

📩 Contact us today to learn how our insole OEM, pillow ODM, and graphene product design services can elevate your product offering—while aligning with the sustainability expectations of modern consumers.Indonesia sustainable material ODM solutions

Researchers found a mutation in the sperm protein FSIP2 lead to infertility in mice. This discovery offers hope for developing infertility treatments. Male infertility affects more than 20 million men globally and is a contributing cause to around 50% of infertility in couples. Frequently, male infertility is the result of defects in the sperm tail, the flagellum, which allows the sperm to swim toward an egg. Males with severe infertility can experience multiple sperm malformations, including flagella that are shortened, irregular, coiled or even absent, preventing them from swimming. In humans, several genetic mutations lead to malformed sperm, including those affecting the sheath that covers the sperm; the mitochondria, which power sperm as they swim; and a tiny sac, the acromosal vesicle, which releases the enzymes that allow one successful sperm to break down the exterior lining of the egg cell to fertilize it. To understand more about the causes of male infertility, Drs Na Li and Ling Sun, research group leaders at Guangzhou Women and Children’s Medical Center, collected sperm samples from infertile men and identified one individual with multiple defects affecting his sperm flagella. Through genetic analysis, they found a mutation in a largely unknown sperm protein, FSIP2 (Fibrous Sheath-Interacting Protein 2), a component of the fibrous sheath. “The fibrous sheath covers the tails of sperm found in humans, mice and other species in which fertilization occurs within the animal’s body”, explains Li. “It offers the sperm tails flexibility and strength, which is necessary for sperm to swim in the dense and sticky medium of the human body before they meet the egg. Interestingly, animals whose sperm swim through water because fertilization occurs outside of the body, such as fish, either do not have the FSIP2 protein or, at most, a defective version.” To study the function of FSIP2, Li, Sun and their team of researchers generated two sets of mice: one in which they recreated the FSIP2 mutation of the human patient and another in which the animals overproduce the FSIP2 protein. They found that mice with the FSIP2 mutation become infertile; their semen contained fewer live sperm and over 50% could not swim forward, even though some of them could still beat their flagella. In contrast, the mice that overproduced the FSIP2 protein remained fertile and, compared to normal mice, had over 7 times more super-long sperm, which could swim faster and be more capable of fertilizing an egg. To understand the reasons for these changes in the sperm flagella, the researchers looked at the composition of the sperm. They found that the sperm of mice with the FSIP2 mutation had lower amounts of the proteins that make up the sheath surrounding the sperm, the mitochondrial power generators and the acrosomal vesicle. In contrast, the sperm of the mice that were overproducing FSIP2 made more sperm tail proteins, particularly in the fibrous sheath, which could allow sperm to swim more easily through the body. They published this discovery in Development. The findings of Li, Sun and their team offer hope that scientists can begin to develop treatments for infertility, either by finding drugs that restore sperm movement or even by finding ways to correct the debilitating mutation that causes the problems in the first place. Ultimately, such treatments could give men suffering from infertility the chance of becoming fathers. Reference: “Hypomorphic and hypermorphic mouse models of Fsip2 indicate its dosage-dependent roles in sperm tail and acrosome formation” by Xiang Fang, Yaser Gamallat, Zhiheng Chen, Hanran Mai, Pei Zhou, Chuanbo Sun, Xiaoliang Li, Hong Li, Shuxin Zheng, Caihua Liao, Miaomiao Yang, Yan Li, Zeyu Yang, Caiqi Ma, Dingding Han, Liandong Zuo, Wenming Xu, Hao Hu, Ling Sun and Na Li, 14 June 2021. Development. DOI: 10.1242/dev.199216

Xibalbanus tulumensis contains toxins that are suitable for the development of active substances against neurological diseases. Credit: Björn M. von Reumont Venom from the marine remipede, Xibalbanus tulumensis, exhibits unique medical potential for treating neurological disorders, showcasing the importance of marine biodiversity in pharmacological research while facing environmental threats. Many animals use venom for self-defense or hunting. The components of venom, known as toxins, affect a wide variety of physiological processes, making them particularly interesting for the development of new pharmacological agents. While the venoms of some animal groups, such as snakes, spiders, scorpions, and insects, have been extensively studied, the venom of marine animal groups remains largely unexplored. Data on marine venoms is limited to individual species, meaning there is significant untapped potential within this group. Discovery of Venomous Crustaceans Several years ago, researchers discovered venomous crustaceans, i.e. remipedes, which resemble centipedes and live in marine underwater caves. A multidisciplinary team led by Dr. Björn von Reumont, who first described the venom system in remipedes in 2014 and is currently a guest researcher at Goethe University Frankfurt, has now characterized a group of toxins from the Xibalbanus tulumensis remipede. To that end, Reumont put together a team consisting of cooperation partners from Fraunhofer Institute for Translational Medicine (ITMP) within the framework of the LOEWE Center for Translational Biodiversity, as well as colleagues from the University of Leuven, from Cologne, Berlin, and Munich – all of them also part of the European Venom Network (COST Action EUVEN). The researchers collect the underwater crab Xibalbanus tulumensis, which only occurs here. Credit: Björn M. von Reumont, Goethe University Frankfurt Potency and Potential of Remipede Toxins The Xibalbanus tulumensis remipede lives in the cenotes which are the underwater cave systems on the Mexican Yucatan peninsula. The cave dweller injects the venom produced in its venom gland directly into its prey. This toxin contains a variety of components, including a new type of peptide, named xibalbine, after its crustacean producer. Some of these xibalbines contain a characteristic structural element that is similar to other toxins, especially those produced by spiders: several amino acids (cysteines) of the peptide are bound to each other in such a manner that they form a knot-like structure. This in turn makes the peptides resistant to enzymes, heat, and extreme pH values. Such knottins often act as neurotoxins, interacting with ion channels and paralyzing prey – an effect that has also been proposed for some xibalbines. The study shows that all the xibalbine peptides tested by the cooperation partners’ doctoral students – and in particular Xib1, Xib2, and Xib13 – effectively inhibit potassium channels in mammalian systems. “This inhibition is greatly important when it comes to developing drugs for a range of neurological diseases, including epilepsy,” says von Reumont. Xib1 and Xib13 also exhibit the ability to inhibit voltage-gated sodium channels, such as those found in nerve or heart muscle cells. In addition, in the sensory neurons of higher mammals, the two peptides can activate two proteins – kinases PKA-II and ERK1/2 – involved in signal transduction. The latter suggests that they are involved in pain sensitization, which opens up new approaches in pain therapy. Cenotes were once sacred to the Maya, as the karst caves were considered the entrance to the divine underworld. Credit: Björn M. von Reumont Conservation and Clinical Potential Although the xibalbines’ bioactivity is exemplary of the untapped potential of marine biodiversity, the production of drugs from animal venoms is a complex and time-consuming process. “Finding suitable candidates and comprehensively characterizing their effects, thus laying the foundation for safe and effective drugs, is only possible today in a large interdisciplinary team, as in the case of our study,” says von Reumont. Making matters more difficult is the fact that time is of the essence for the remipedes. Their habitat is under serious threat from the construction of the Tren Maya intercity railroad network, which cuts straight through the Yucatan Peninsula. “The cenotes are a highly sensitive ecosystem,” explains von Reumont, who, as an experienced cave diver, has collected remipedes in Yucatan during several cave diving expeditions. “Our study highlights the importance of protecting biodiversity, not only for its ecological significance, but also for potential substances that could be of crucial importance to us humans.” Reference: “Diversely evolved xibalbin variants from remipede venom inhibit potassium channels and activate PKA-II and Erk1/2 signaling” by Ernesto Lopes Pinheiro-Junior, Ehsan Alirahimi, Steve Peigneur, Jörg Isensee, Susanne Schiffmann, Pelin Erkoc, Robert Fürst, Andreas Vilcinskas, Tobias Sennoner, Ivan Koludarov, Benjamin-Florian Hempel, Jan Tytgat, Tim Hucho and Björn M. von Reumont, 29 July 2024, BMC Biology. DOI: 10.1186/s12915-024-01955-5

Messenger RNA (mRNA) acts as a blueprint for protein production, with certain chemical modifications like m6A acting as regulatory “comments” to control processes like degradation. Researchers at the University of Würzburg discovered that m6A triggers fast and efficient mRNA degradation, providing insights that could aid in developing drugs to fine-tune protein production. Researchers discovered that the mRNA modification m6A triggers rapid degradation, regulating protein production. This breakthrough could inform drug development to manage protein-related diseases. Messenger ribonucleic acids (mRNA) are like the architects of our bodies. They carry precise blueprints for building proteins, which are read and assembled by their cellular partners, the ribosomes. Proteins are essential for our survival, as they regulate cell division, bolster the immune system, and make our cells resilient against external threats. Just like in real-world construction, some cellular blueprints require extra instructions—such as when a protein needs to be produced rapidly or when corrections are needed for a flawed design. In our bodies, this role is fulfilled by RNA modifications. These small chemical changes function like detailed annotations, offering additional guidance to specific parts of the mRNA for optimal protein production. New Degradation Process for MRNA Discovered Researchers at the University of Würzburg (JMU) in Bavaria, Germany, have now focused on a specific modification, N6-methyladenosine (m6A). “m6A is interesting for science because this modification is often altered in people who suffer from metabolic disorders, cancer or heart disease,” explains bioinformatician Kathi Zarnack. “Its function: When m6A is attached to an mRNA, it triggers the degradation of the mRNA as soon as the first proteins have been produced according to the blueprint it contains. This is particularly important for proteins, of which too many must not be produced as this would be harmful to the cell.” The Würzburg researchers were the first to discover and observe this degradation process: It couples the degradation of an mRNA directly to the proteins produced and is significantly faster and more efficient than previously known mechanisms for mRNA degradation. Crucially, this particular pathway only works when m6A is present in specific regions of the mRNA. In this way, m6A particularly “comments” on the blueprints for proteins involved in cell differentiation – that is, whether a cell will exist as a nerve cell, muscle cell, skin cell, or some other form. Drugs that control the addition of m6A to mRNA could take advantage of this process. By specifically suppressing m6A, it would be possible to produce more proteins with desirable functions – and, conversely, to inhibit the production of undesirable proteins. The problem: Until now, it has been difficult for scientists to predict the effects of such drugs because it was not known in which regions of the mRNA the m6A modification had to be located in order to trigger degradation. “With our study, we are now contributing to a better understanding and more precise prediction of which mRNAs are particularly sensitive to these drugs”, says biochemist and RNA biologist Julian König, Zarnack’s colleague. Next Research Steps In the future, the researchers plan to investigate in more detail how m6A-marked mRNA is degraded, for example, how ribosomes recognize the modification, and how targeted mRNA degradation by m6A can be used clinically. Reference: “m6A sites in the coding region trigger translation-dependent mRNA decay” by You Zhou, Miona Ćorović, Peter Hoch-Kraft, Nathalie Meiser, Mikhail Mesitov, Nadine Körtel, Hannah Back, Isabel S. Naarmann-de Vries, Kritika Katti, Aleš Obrdlík, Anke Busch, Christoph Dieterich, Štěpánka Vaňáčová, Martin Hengesbach, Kathi Zarnack and Julian König, 21 November 2024, Molecular Cell. DOI: 10.1016/j.molcel.2024.10.033 In addition to the Würzburg researchers, the Institute of Molecular Biology (IMB) in Mainz and the Goethe University in Frankfurt are also involved in the study, which is funded by the German Research Foundation as part of the Collaborative Research Centre TRR 319 “RMaP: RNA Modification and Processing.”

DVDV1551RTWW78V